Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
A40 | Alita Resources Limited Announcement | 20/07/25 | 70 | 52K | |||
|
|||||||
A40 | Alita Resources Website | 17/05/25 | 1 | 1.3K | |||
|
|||||||
A40 | AGM Notes - 28 March 2025 | 15/05/25 | 15 | 9.2K | |||
|
|||||||
A40 | LIQUIDATION & BALD HILL FOR SALE | 01/03/25 | 1.9K | 871K | |||
|
|||||||
A40 | Bald Hill Worth $2B+ #StrongerTogether | 05/12/24 | 11 | 9.2K | |||
|
|||||||
A40 | Justice Hill - Queen Bee | 28/12/23 | 18 | 12K | |||
|
|||||||
A40 | BANTON GROUP / NORTON ROSE FULBRIGHT | 19/12/23 | 43 | 21K | |||
|
|||||||
A40 | Min Res loses $46000000 | 05/12/23 | 1 | 2.1K | |||
|
See All Discussions